Aquavit Pharmaceuticals Announces Official Launch of AQUAGOLD® fine touch™ at the 72nd AAD Meeting
Denver, COLORADO, March 23, 2014 Aquavit Pharmaceuticals, Inc., a New York-based technology-driven life science company, officially...
top of page
Search
Aquavit Pharmaceuticals Appoints David J. Goldberg as CMO; Launching AQUAGOLD® at AAD
New York City, NEW YORK, March 5, 2014 Aquavit Pharmaceuticals, Inc., a private high-tech life science company, announced today the...
AQUAGOLD® fine touch™ showcased at 2014 South Beach Symposium
Miami Beach, Florida, February 17, 2014 AQUAGOLD® fine touch™ was presented at the 2014 South Beach Symposium in Miami during a session...
AQUAGOLD® fine touch™ Presented at the 2014 IMCAS by Dr. David Goldberg
Paris, France, February 5, 2014 AQUAGOLD® fine touch™ was featured at the 2014 International Master Course on Aging Skin Conference...
AQUAGOLD® fine touch™ featured at Winter Clinical Dermatology Meeting
Kohala Coast, HAWAII, January 19, 2014 AQUAGOLD® fine touch™ was featured at the 2014 Winter Clinical Dermatology Conference in Hawaii...
Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio
NEW YORK, Nov. 5, 2013 Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding...
Aquavit Pharmaceuticals Adds New Advanced Drug Delivery Technology to Product Portfolio
New York. Nov. 5, 2013 Aquavit Pharmaceuticals, Inc. has further extended its personalized drug delivery platform by signing a binding...
Aquavit Appoints David Shafer, MD., FACS., New Chief Medical Technology Officer
NEW YORK, March 4, 2013 Aquavit Pharmaceuticals Inc. has announced its newest addition to its management team, Dr. David Shafer . He has...
Dr. B.G. Rhee Joins Aquavit’s Advisory Board
SEOUL & NEW YORK, January 21, 2013 We are pleased to announce that Dr. B.G. Rhee has signed on as a member of Aquavit Pharmaceutical’s...
Aquavit Pharmaceuticals Selects Uniquest for New High-Tech Medical Device Manufacturing
NEW YORK, December 12, 2012 Aquavit Pharmaceuticals, a privately held specialty pharmaceuticals and medical device company, has signed a...
Aquavit Pharmaceuticals and Uniquest sign MOU for Alliance Partnership
SEOUL & NEW YORK, October 8, 2012 Aquavit Life Sciences, Inc, a wholly owned subsidiary of Aquavit Pharmaceuticals, Inc, announces...
Aquavit Pharmaceuticals forms Alliance Partnership with Accelrys
NEW YORK Sept. 21, 2012/PRNewswire/ — Aquavit Pharmaceuticals, Inc. and Accelrys Software Inc. (NASDAQ: ACCL), a leader in scientific...
Aquavit and Green Cross sign Strategic Collaboration MOU on IBX-001 Product Development in Asia
SEOUL & NEW YORK, August 8, 2012 Aquavit Pharmaceuticals, Inc. and Green Cross Corp. (006280:Korea SE), a leading biotechnology company...
Video Interview with Dr. Steven Fagien
NEW YORK, April 11, 2012 In a featured web article for the University of Florida, Dr. Steven Fagien was put under the Alumni Spotlight....
Dr. Steven Fagien appointed as Chairman, Scientific Advisory Board
NEW YORK, February 1, 2012 Steve Fagien MD has joined us as Aquavit as chairman of the Scientific Advisory Board. As a world-class...
IMCAS Paris 2012
PARIS, FRANCE, January 30, 2012 Aquavit Pharmaceuticals, Inc. made its debut at IMCAS Paris on January 27, 2012. The company received a...
Aquavit Pharmaceuticals Implements First-of-Kind Accelerate-to-Market Strategy
NEW YORK, September 2, 2011 Sobin Chang, CEO joined MBA students and faculty members at HAAS Business School, University of California at...
News: Blog2
bottom of page